.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has demonstrated varied performance across different Canadian provinces and product categories. In Alberta, the brand has maintained a strong presence in the Capsules category, consistently ranking in the top four from August to November 2024. This stability highlights their robust market position in this segment, despite a slight dip in sales in September. Conversely, their performance in the Concentrates category shows a positive trend, moving from 18th place in September to 14th in November, which suggests a growing consumer interest and possibly successful market strategies implemented by the brand.
In British Columbia, Stigma Grow's Capsules have shown an upward trajectory, improving their rank from 7th to 6th over the same period, indicating a strengthening foothold in the market. However, their rank in the Concentrates category remained relatively stable, hovering around the 17th and 18th positions, which might suggest challenges in gaining a competitive edge in this segment. Meanwhile, in Ontario, they have maintained a steady position in the top 10 for Capsules, but their Concentrates have not broken into the top 30, indicating a potential area for growth or reevaluation of strategy.
Competitive Landscape
In the Alberta capsules market, Stigma Grow has experienced fluctuating rankings and sales over the past few months. Initially holding the 3rd position in August and September 2024, Stigma Grow dropped to 4th place in October before reclaiming the 3rd spot in November. This fluctuation is significant as it highlights the competitive pressure from brands like Tweed, which improved its rank from 4th to 2nd over the same period, and Glacial Gold, consistently maintaining the top position. Despite the rank changes, Stigma Grow's sales showed a slight recovery in November after a decline in the previous months, suggesting a potential stabilization or strategic adjustment in response to competitive dynamics. Meanwhile, Emprise Canada and Frank maintained lower ranks, indicating that Stigma Grow remains a strong contender in the mid-tier segment of this market.
Notable Products
In November 2024, Stigma Grow's top-performing product was the Indica RSO Capsules 25-Pack (250mg), maintaining its first-place ranking from previous months with a notable sales figure of 5730 units. The Phoenix Tears RSO (1g) consistently held the second position, reflecting steady demand across the months. CBD Softgels 15-Pack (750mg CBD) also maintained its third-place ranking, indicating stability in customer preference for this product. The Phoenix Tears Resin (1g) and Phoenix Tears Honey Oil (1g) remained in fourth and fifth positions respectively, showing little change in their rankings from October. Overall, the top products for November have shown consistent performance with slight sales increases, particularly for the leading Indica RSO Capsules.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
